Company news

Metis TechBio Co., Ltd. news in 2026

Metis TechBio Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026

November 4, 2026

Voluntary announcement Metis TechBio entered strategic collaboration with lilly to advance next-generation tissue-specific LNP delivery technologies

October 19, 2026

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

October 6, 2026

2026 Interim Report

September 29, 2026

METiS TechBio and Boulevard Bio Enter Global License Agreement for Trispecific T-cell Engager

June 30, 2026

METiS TechBio to Present Late-Breaking Data on Near-Complete Cardiomyocyte Delivery at CRS 2026

May 20, 2026

Decks in 2026